Robert E. Hurst

Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel.

SBH Sciences, Inc. offers biotechnology products and services for discovery research. The private company is based in Natick, MA. The company support startup companies, entrepreneur scientists, and the biotechnology industry to helps shorten timelines and reduce costs. The company also provides precise and reliable biomarker evaluations for veterinary and in vivo studies of rats, pigs, equines, and canines.

Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY.

Sky Ventures International LLC (Sky Ventures) is a venture capital firm founded in 2015 by Eyal Geffen and Raphael Nir. The firm is headquartered in Boston, Massachusetts.

NeuroDex, Inc. engages in the development of a research platform focuses on diagnostics, theranostics, prognostics, and pharmacodynamic analysis. It offers ExoSORT that combines bioinformatics and state-of-the-art laboratory processes. The company was founded by Erez Eitan and Oded Biran in 2018 and is headquartered in Arlington, MA.

Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization.